Table 1 Patient and tumor characteristics and their relationship with CAFs prevalence
N | Positive for CAFs N (%) | P value | |
|---|---|---|---|
Age (year) | 2.77a | ||
≤60 | 47 | 22 (46.81) | |
>60 | 53 | 29 (54.72) | |
Sex | 5.11a | ||
Male | 57 | 32 (56.14) | |
Female | 43 | 19 (44.19) | |
Location of the tumor | 1.35b | ||
Proximal end of stomach (1/3) | 13 | 9 (69.23) | |
Gastric body (1/3) | 19 | 9 (47.37) | |
Remote end of stomach (1/3) | 51 | 22 (43.14) | |
More than 1/3 of the stomach involved | 17 | 11 (64.71) | |
Tumor differentiation | 0.56b | ||
Well differentiated | 16 | 7 (43.75) | |
Moderate differentiated | 44 | 24 (54.55) | |
Poorly differentiated | 25 | 16 (64.00) | |
Undifferentiated | 15 | 4 (26.67) | |
Tumor size | 0.02a | ||
≤5 cm | 62 | 16 (35.48) | |
>5 cm | 38 | 29 (76.32) | |
Depth of tumor (T) | 0.03b | ||
Tis | 4 | 1 (25.00) | |
T1 | 13 | 5 (38.46) | |
T2 | 39 | 19 (48.72) | |
T3 | 26 | 15 (57.69) | |
T4 | 18 | 11 (61.11) | |
Lymph node metastasis (N) | <0.01a | ||
N0 | 46 | 16 (34.78) | |
N1-3 | 54 | 35 (64.81) | |
Liver metastasis | <0.01a | ||
Yes | 12 | 9 | |
No | 88 | 42 | |
Peritoneum metastasis | <0.01a | ||
Yes | 9 | 7 (77.77) | |
No | 91 | 44 (48.35) | |
TNM Stage | <0.01b | ||
IA | 15 | 3 (20) | |
IB | 7 | 2 (28.57) | |
II | 19 | 6 (31.58) | |
IIIA | 23 | 11 (47.83) | |
IIIB | 15 | 8 (53.33) | |
IV | 21 | 14 (66.67) |